ADAP News and Press, Adaptimmune Therapeutics plc From 10/16/19

In our most recent article, we focused on Iovance ( IOVA ), a cell therapy company that in our opinion has consistently generated positive data, has developed a commercializable product, and is deploying a de-risked clinical strategy for a clear unmet need. As a result, we saw nearly 100% ups...

Adaptimmune Therapeutics ( ADAP ) is a good speculative biotech to look into in considering to add to the portfolio. That's because it announced some preliminary positive data in patients with synovial sarcoma . On the flip side, the data was only achieved in a phase 1 study. There is a c...

Adaptimmune Therapeutics (NASDAQ: ADAP ) announces a 3-year agreement with Cryoport (NASDAQ: CYRX ) to use latter's logistics solutions for its cell therapies. More news on: Adaptimmune Therapeutics plc, Cryoport, Inc., Healthcare stocks news, Read more ...

PHILADELPHIA and OXFORDSHIRE, United Kingdom and IRVINE, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, and Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), the world's leading temperatur...

Gainers:  Akcea Therapeutics (NASDAQ: AKCA ) +29% . Liquid Media Group (NASDAQ: YVR ) +24% . AgeX Therapeutics (NYSEMKT: AGE ) +20% . Sutro Biopharma (NASDAQ: STRO ) +19% . Livongo Health (NASDAQ: LVGO ) +15% . Motus GI Holdings (NASDAQ: MOTS ) +12% . Teekay Tankers (NYSE: TNK )...

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, announces the appointment of Michael Garone as interim Chief Financial Officer (CFO) effective immediately. &#...

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, presented updated data from patients with synovial sarcoma who were treated in the ongoing Phase 1 trial with SP...

Gainers:  Francesca's Holdings (NASDAQ: FRAN ) +92% . Mallinckrodt plc (NYSE: MNK ) +64% . Pier 1 Imports (NYSE: PIR ) +41% . YRC Worldwide (NASDAQ: YRCW ) +32% . Endo International (NASDAQ: ENDP ) +29% . Dean Foods Company (NYSE: DF ) +28% . Basic Energy Services (NYSE: BAS ) ...

The FDA has granted Orphan Drug Designation (ODD) to Adaptimmune Therapeutics' (NASDAQ: ADAP ) SPEAR T-cells targeting MAGE-A4 (ADP-A2M4 program) for the treatment of soft tissue sarcomas. More news on: Adaptimmune Therapeutics plc, Healthcare stocks news, Read more ...

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to SPE...